{
  "id": 2296,
  "text": "compl.Intraoperative complications, LE Lymphoepithelioma, NA not applicable, NK non-keratinizing, nr not reported, PC planocellular carcinoma, recurr.recurrence, SCC squamous cell carcinoma # 17 Acronyms and abbreviations 3D 3-dimensional 5-FU 5-fluorouracil ACC adenocarcinoma ACPG alberta clinical practice guidelines AGDH australian government department of health AHRQ agency for healthcare research and quality AM adenoma malignum AQuAS agència de qualitat i avaluació sanitàries de Catalunya ARH abdominal radical hysterectomy ASqC adenosquamous carcinoma ASCO american society of clinical oncology AWD alive with disease BCCA british columbia cancer agency BMI body mass index BT brachytherapy CA 125 cancer antigen 125 CA 15-3 cancer antigen 15-3 CADTH canadian agency for drugs and technologies in health CCIP cervical cancer in pregnancy CCO cancer care ontario CCRT concurrent chemoradiotherapy CEA carcinoembryonic antigen CEPO comité de l’évolution des pratiques en oncologie CES-D epidemiologic studies depression scale CI confidence interval CIC circulating immune complexes CIN cervical intraepithelial neoplasia CKC cold knife conisation CoCanCPG coordination of cancer clinical practice guidelines COMPAQ-HPST coordination pour la mesure de la performance et l’amélioration de la qualité, hôpital, patient, sécurité, territoire CR complete response CRS conventional radical surgery CS cesarean section CT computed tomography CTV-THR high-risk clinical target volume CTV-TIR intermediate-risk clinical target volume CYFRA 21-1 cytokeratin fragment 21-1 DFS disease-free survival DOD dead of disease DSS disease-specific survival EBRT external beam radiotherapy EORTC european organization for research and treatment of cancer EORTC-CGC european organization for research and treatment of cancer-gynecological cancer group EQD2 equi-effective dose to 2 Gy ESGO european society of gynaecological oncology ESMO european society of medical oncology ESP european society of pathology ESTRO european society for radiotherapy and oncology FACT- $.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: compl.Intraoperative complications, LE Lymphoepithelioma, NA not applicable, NK non-keratinizing, nr not reported, PC planocellular carcinoma, recurr.recurrence, SCC squamous cell carcinoma # 17 Acronyms and abbreviations 3D 3-dimensional 5-FU 5-fluorouracil ACC adenocarcinoma ACPG alberta clinical practice guidelines AGDH australian government department of health AHRQ agency for healthcare resea\n\n<question>: ",
  "ChatGPT_response_0": "在手术中遇到并发症或治疗中的困难时，我更倾向于寻求来源权威、经过验证的临床实践指南或治疗建议。这些指南通常基于最新的临床研究和实践经验，能够提供针对特定情况的详细指导，帮助医生做出更明智的决策。同时，值得注意的是，根据患者具体的病情和情况，医生也可能会结合个体化治疗方案，综合考虑各种因素来找到最佳的治疗方法。",
  "query": "在手术中遇到并发症或者治疗中的困难时，您更倾向于寻求何种类型的临床实践指南或治疗建议？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在手术中遇到并发症或者治疗中的困难时，您更倾向于寻求何种类型的临床实践指南或治疗建议？\n\n<reference text>: compl.Intraoperative complications, LE Lymphoepithelioma, NA not applicable, NK non-keratinizing, nr not reported, PC planocellular carcinoma, recurr.recurrence, SCC squamous cell carcinoma # 17 Acronyms and abbreviations 3D 3-dimensional 5-FU 5-fluorouracil ACC adenocarcinoma ACPG alberta clinical practice guidelines AGDH australian government department of health AHRQ agency for healthcare research and quality AM adenoma malignum AQuAS agència de qualitat i avaluació sanitàries de Catalunya ARH abdominal radical hysterectomy ASqC adenosquamous carcinoma ASCO american society of clinical onco\n\n<reply>: ",
  "response": "在手术中遇到并发症或治疗中的困难时，我更倾向于寻求来源权威、经过验证的临床实践指南或治疗建议。这些指南通常基于最新的临床研究和实践经验，能够提供针对特定情况的详细指导，帮助医生做出更明智的决策。同时，值得注意的是，根据患者具体的病情和情况，医生也可能会结合个体化治疗方案，综合考虑各种因素来找到最佳的治疗方法。"
}